About: Drug and medical device product failures and the stability of the pharmaceutical supply chain

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Drug and medical device product failures and the stability of the pharmaceutical supply chain Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Drug and medical device product failures and the stability of the pharmaceutical supply chain
Creator	Joseph, T Livingston, Alex Ii, Mattingly
Source	Elsevier; Medline; PMC
abstract	OBJECTIVE: Our objective was to review recent drug and medical device recalls, categorize recall types based on the free text descriptions posted within the recall announcements, and conduct exploratory analyses for researchers interested in pharmaceutical supply chain challenges. METHODS: A cross-sectional study of all current recalls, market withdrawals, and safety alerts published by the United States Food and Drug Administration pertaining to drugs was conducted. A manual review of all the recalls was also conducted to extract additional information including company details, recall type (labeling or quality), and location of failure in the pharmaceutical supply chain (manufacturing or distribution). Descriptive statistics and exploratory bivariate analyses were conducted to test any potential differences between drug and device recalls. RESULTS: Most recalls issued between January 2017 and September 2019 were pharmaceutical drug recalls (85.2%), while 34 (14.8%) medical device recalls were issued for the same period. For drug recalls, 85.1% (166/195) were because of quality, while 14.9% (29/195) were because of labeling issues. Of the quality issues for drug recalls, lack of sterility was the most frequent issue (139/166, 83.7%). There was no difference between drug or device recalls based on recall type (P = 0.16), top 20 pharmaceutical company (P = 0.62), or location of the supply chain failure (P = 0.20). CONCLUSIONS: This study provides a process to categorize and evaluate drug and device recalls by recall type and location of the supply chain. By categorizing the free text provided in public recall data it would be easier to monitor trends over time.
has issue date	2020-08-01(xsd:dateTime)
bibo:doi	10.1016/j.japh.2020.07.005
bibo:pmid	32753251
has license	no-cc
sha1sum (hex)	a937d8e6644bca2adad00527e642aec16efa13ff
schema:url	https://doi.org/10.1016/j.japh.2020.07.005
resource representing a document's title	Drug and medical device product failures and the stability of the pharmaceutical supply chain
has PubMed Central identifier	PMC7395820
has PubMed identifier	32753251
schema:publication	J Am Pharm Assoc (2003)
resource representing a document's body	covid:a937d8e6644bca2adad00527e642aec16efa13ff#body_text
is schema:about of	named entity 'location' named entity 'text' named entity 'supply chain' named entity 'This' named entity 'period' named entity 'Methods' named entity 'recalls' named entity 'supply chain' named entity 'TIME' named entity 'RECALL' named entity 'INTERESTED' named entity 'MARKET' named entity 'SAFETY' named entity 'DESCRIPTIVE STATISTICS' named entity '28139' named entity 'TYPE' named entity 'PROVIDES' named entity 'DETAILS' named entity 'CHAIN' named entity 'CATEGORIZING' named entity 'REVIEW OF' named entity 'DATA' named entity 'DISTRIBUTION' named entity 'LACK' named entity '2019' named entity '28166' named entity 'ALERTS' named entity 'BASED' named entity 'DRUGS' named entity 'PHARMACEUTICAL' named entity 'device' named entity 'labeling' named entity 'drug' named entity 'recall' named entity 'additional' named entity 'evaluate' named entity 'Administration' named entity 'product quality' named entity 'Class III medical devices' named entity 'recalls' named entity 'categorize' named entity 'pharmaceutical company' named entity 'NLP' named entity 'FDA' named entity 'pharmaceutical company' named entity 'future research' named entity 'premarket approval' named entity 'pharmaceutical companies' named entity 'sterility' named entity 'nutritional supplement' named entity 'U.S.' named entity 'objective' named entity 'There' named entity 'drug' named entity 'posted' named entity 'pharmaceutical drug' named entity 'public recall' named entity 'supply chain' named entity 'supply chain' named entity 'pharmaceutical' named entity 'medical device' named entity 'FDA' named entity 'analyzing data' named entity 'sterility' named entity 'adverse events' named entity 'medical device' named entity 'supply chain' named entity 'supply chain' named entity 'FDA' named entity 'sterility' named entity 'product quality' named entity 'Food and Drug Administration' named entity 'dietary supplement' named entity 'Product Quality' named entity 'Subsidiaries' named entity 'paliperidone' named entity 'Current Good Manufacturing Practices' named entity 'product quality' named entity 'United States'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software